Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) FCF Margin (2016 - 2025)

Collegium Pharmaceutical (COLL) has 10 years of FCF Margin data on record, last reported at 630.43% in Q4 2025.

  • For Q4 2025, FCF Margin fell 67744.0% year-over-year to 630.43%; the TTM value through Dec 2025 reached 100.89%, up 6846.0%, while the annual FY2025 figure was 397.98%, 43041.0% down from the prior year.
  • FCF Margin reached 630.43% in Q4 2025 per COLL's latest filing, down from 362.87% in the prior quarter.
  • Across five years, FCF Margin topped out at 130.41% in Q4 2021 and bottomed at 630.43% in Q4 2025.
  • Average FCF Margin over 5 years is 15.16%, with a median of 34.16% recorded in 2022.
  • Peak YoY movement for FCF Margin: skyrocketed 10275bps in 2021, then plummeted -67744bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 130.41% in 2021, then crashed by -61bps to 50.44% in 2022, then decreased by -3bps to 48.87% in 2023, then decreased by -4bps to 47.01% in 2024, then crashed by -1441bps to 630.43% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 630.43% in Q4 2025, 362.87% in Q3 2025, and 38.5% in Q2 2025.